Home
    Disclaimer
    Glutethimide molecular structure

    Glutethimide Stats & Data

    Glimid Doriden Noxyron Elrodorm
    Chemical Class Opioid
    Psychoactive Class Depressant

    Pharmacology

    DrugBank
    Half-life 10-12 hours State Solid Absorption Variable

    Description

    Glutethimide is a hypnotic and sedative. Its use has been largely superseded by other drugs.

    Mechanism of Action

    Glutethimide seems to be a GABA agonist which helps induce sedation. It also induces CYP 2D6. When taken with codeine, it enables the body to convert higher amounts of codeine (higher than the average 5 - 10%) to morphine. This combination of effects enhances sedation.

    Pharmacodynamics

    Glutethimide, like the barbiturates, is a hypnotic sedative. It was introduced in 1954 as a safer alternative to barbiturates but was soon determined to be just as likely to cause addiction and withdrawal symptoms.

    Metabolism

    Hepatic. Glutethimide is almost completely metabolized.

    Toxicity

    In adults, death has been reported after 5 g. The usual lethal dose is 10 to 20g, although survival after a dose of 28 g has been reported.

    Indication

    For the treatment of insomnia.

    Elimination

    glutethimide is inactivated by conjugation and the metabolites are excreted in urine, only 2% of the parent substance is excreted in urine, up to 2% of the dose has been reported to be found in the faeces.

    Effect Profile

    Curated
    Opioid 5.4

    Strong euphoria with mild sedation and itching/nausea

    Euphoria / Warmth×3
    9
    Analgesia×2
    0
    Sedation / Relaxation×1
    5
    Itching / Nausea×1
    4

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1d Half tolerance 21d Baseline ~35d
    ← Back to Glutethimide